These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23943595)

  • 1. Glucocorticoids antagonize RUNX2 during osteoblast differentiation in cultures of ST2 pluripotent mesenchymal cells.
    Koromila T; Baniwal SK; Song YS; Martin A; Xiong J; Frenkel B
    J Cell Biochem; 2014 Jan; 115(1):27-33. PubMed ID: 23943595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids Hijack Runx2 to Stimulate Wif1 for Suppression of Osteoblast Growth and Differentiation.
    Morimoto E; Li M; Khalid AB; Krum SA; Chimge NO; Frenkel B
    J Cell Physiol; 2017 Jan; 232(1):145-53. PubMed ID: 27061521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells.
    Baniwal SK; Shah PK; Shi Y; Haduong JH; Declerck YA; Gabet Y; Frenkel B
    Osteoporos Int; 2012 Apr; 23(4):1399-413. PubMed ID: 21881969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids inhibit the maturation of committed osteoblasts via SOX2.
    Chen JH; Shen C; Oh HR; Park JH
    J Mol Endocrinol; 2022 Apr; 68(4):195-207. PubMed ID: 35255002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation.
    Ito S; Suzuki N; Kato S; Takahashi T; Takagi M
    Bone; 2007 Jan; 40(1):84-92. PubMed ID: 16949358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation.
    Liu P; Baumgart M; Groth M; Wittmann J; Jäck HM; Platzer M; Tuckermann JP; Baschant U
    Sci Rep; 2016 Aug; 6():32112. PubMed ID: 27554624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone promotes DMP1 mRNA expression by inhibiting negative regulation of Runx2 in multipotential mesenchymal progenitor, ROB-C26.
    Mikami Y; Takahashi T; Kato S; Takagi M
    Cell Biol Int; 2008 Feb; 32(2):239-46. PubMed ID: 17950631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells.
    Hong D; Chen HX; Xue Y; Li DM; Wan XC; Ge R; Li JC
    J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):86-92. PubMed ID: 19460432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2.
    Luppen CA; Leclerc N; Noh T; Barski A; Khokhar A; Boskey AL; Smith E; Frenkel B
    J Biol Chem; 2003 Nov; 278(45):44995-5003. PubMed ID: 12933820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epithelial sodium channel is involved in dexamethasone-induced osteoblast differentiation and mineralization.
    Lu L; Wu L; Jia H; Li Y; Chen J; Xu D; Li Q
    Cell Biol Toxicol; 2012 Oct; 28(5):279-89. PubMed ID: 22752439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway.
    Richardson JA; Amantea CM; Kianmahd B; Tetradis S; Lieberman JR; Hahn TJ; Parhami F
    J Cell Biochem; 2007 Apr; 100(5):1131-45. PubMed ID: 17031848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs).
    Rimando MG; Wu HH; Liu YA; Lee CW; Kuo SW; Lo YP; Tseng KF; Liu YS; Lee OK
    Sci Rep; 2016 Nov; 6():37371. PubMed ID: 27901049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced differentiation of primary cultured bone marrow mesenchymal cells into adipocytes is antagonized by exogenous Runx2.
    Lin L; Dai SD; Fan GY
    APMIS; 2010 Aug; 118(8):595-605. PubMed ID: 20666741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) protein negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation through suppressing runt-related gene 2 (Runx2) activity.
    Lee KN; Jang WG; Kim EJ; Oh SH; Son HJ; Kim SH; Franceschi R; Zhang XK; Lee SE; Koh JT
    J Biol Chem; 2012 Jun; 287(23):18888-99. PubMed ID: 22493443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells.
    Johnson TE; Vogel R; Rutledge SJ; Rodan G; Schmidt A
    Endocrinology; 1999 Jul; 140(7):3245-54. PubMed ID: 10385421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells.
    Mikami Y; Omoteyama K; Kato S; Takagi M
    Biochem Biophys Res Commun; 2007 Oct; 362(2):368-73. PubMed ID: 17707772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo.
    Hildebrandt S; Baschant U; Thiele S; Tuckermann J; Hofbauer LC; Rauner M
    Sci Rep; 2018 Jun; 8(1):8711. PubMed ID: 29880826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitexin enhances osteoblast differentiation through phosphorylation of Smad and expression of Runx2 at in vitro and ex vivo.
    Kim KM; Son HE; Min HY; Jang WG
    Mol Biol Rep; 2020 Nov; 47(11):8809-8817. PubMed ID: 33118104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss.
    Shen GY; Ren H; Shang Q; Zhao WH; Zhang ZD; Yu X; Huang JJ; Tang JJ; Yang ZD; Liang D; Jiang XB
    Int J Biol Sci; 2019; 15(10):2182-2197. PubMed ID: 31592234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.